SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Adimmune Corp revenue rises to NT$97.9M for Aug; prior NT$72.8M

Adimmune Corp reports August revenue of NT$97,916,000 versus NT$72,821,000 in 2025. January–August revenue is NT$555,205,000 versus NT$493,239,000 in 2025, per Taiwan Stock Exchange figures.

4142

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories